| Abstrakt: |
Keywords: Oxford; United Kingdom; Europe; Cancer Research; Clinical Trials and Studies; Drugs and Therapies; Enzymes and Coenzymes; Genetics; Health and Medicine; Polymerase; Pre-Trial Research; Radiotherapy EN Oxford United Kingdom Europe Cancer Research Clinical Trials and Studies Drugs and Therapies Enzymes and Coenzymes Genetics Health and Medicine Polymerase Pre-Trial Research Radiotherapy 371 371 1 05/22/23 20230523 NES 230523 2023 MAY 23 (NewsRx) -- By a News Reporter-Staff News Editor at Clinical Trials Week -- Research findings on Cancer Research are discussed in a new report. Financial supporters for this research include CRUK RadNet Oxford Centre (Cancer Research UK), Cancer Research UK, Cancer Research UK, European Research Council Advanced Investigator, Wellcome Trust, Medical Research Council UK (MRC), Wellcome Trust, Engineering & Physical Sciences Research Council (EPSRC), Cancer Research UK, BTC, Howat Foundation. According to news originating from Oxford, United Kingdom, by NewsRx correspondents, research stated, "DNA polymerase theta (Pol theta, encoded by the POLQ gene) is a DNA repair enzyme critical for microhomology medi-ated end joining (MMEJ). [Extracted from the article] |
